Global Oncology Drugs Market Size To Worth USD 564.50 Billion By 2033 | CAGR Of 11.50% [Yahoo! Finance]
Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Yahoo! Finance
USD 564.50 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered: Pfizer Inc, Amgen Inc., Novartis AG, GSK plc, Eli Lilly and Company, AstraZeneca PLC, AbbVie Inc., Ono Pharmaceutical Company, Johnson and Johnson, Astellas Pharma Inc, Bayer Healthcare, Hoffmann-La Roche Ltd., and Others Key Vendors. New York, United States , June 18, 2024 (GLOBE NEWSWIRE) -- The Global Oncology Drugs Market Size is to Grow from USD 190.10 Billion in 2023 to USD 564.50 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 11.50% during the projected period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4487 Oncology drugs are medications used to treat cancer, a category of disorders caused by the uncontrolled development and division of abnormal cells, they include chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Major pharmaceutical companies focus on innovation to improve treatments,
Show less
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- Regeneron Pharmaceuticals Suffers Worst Month in Two Years After Legal Setback [Yahoo! Finance]Yahoo! Finance
- Amgen Inc. (NASDAQ: AMGN) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $405.00 price target on the stock.MarketBeat
- AMGN Stock Falls Despite Upbeat Data on Immunology Drugs: Here's Why [Yahoo! Finance]Yahoo! Finance
- Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $362.00 price target on the stock.MarketBeat
- Amgen Inc. (NASDAQ: AMGN) had its "underperform" rating re-affirmed by analysts at Robert W. Baird. They now have a $215.00 price target on the stock.MarketBeat
AMGN
Earnings
- 8/6/24 - Beat
AMGN
Sec Filings
- 8/13/24 - Form 4
- 8/13/24 - Form 4
- 8/13/24 - Form 4
- AMGN's page on the SEC website